About NightWatch
NightWatch is a company based in Leiden (Netherlands) founded in 2013 by Mark Bloemendaal, Asmund Tielen, and Asmund Tielens. NightWatch offers products and services including NightWatch Device. NightWatch operates in a competitive market with competitors including Empatica, NeuroPace, Seer, Cadence Neuroscience and Epitel, among others.
- Headquarter Leiden, Netherlands
- Founders Mark Bloemendaal, Asmund Tielen, Asmund Tielens
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Livassured B.V.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$55.29 K (USD), Grant
Mar 31, 2020
-
Investors
European Union
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NightWatch
NightWatch offers a comprehensive portfolio of products and services, including NightWatch Device.
Wearable system for detecting and alerting epileptic seizures during sleep.
Funding Insights of NightWatch
Investors in NightWatch
NightWatch has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Oost NL and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Sector-agnostic VC firm investing in geographies such as the Netherlands
|
Locked | Locked | Locked | |
|
Health Innovations is focused on investing in healthcare improvements.
|
Locked | Locked | Locked |
Investor details for NightWatch
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NightWatch
Investment portfolio details for NightWatch
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NightWatch
Detailed financials for NightWatch
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nightwatch Comparisons
Peer comparison for NightWatch
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NightWatch
NightWatch operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Empatica, NeuroPace, Seer, Cadence Neuroscience and Epitel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a wrist band to monitor physiological signals
|
|
| Locked | Locked | Locked |
Implantable neurostimulation systems for epilepsy treatment are developed.
|
|
| Locked | Locked | Locked |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| Locked | Locked | Locked |
Medical devices for treating neurological disorders like epilepsy are developed.
|
|
| Locked | Locked | Locked |
Wearable EEG system for epilepsy monitoring and control is provided.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for epilepsy patients
|
Detailed competitors of NightWatch
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nightwatch
Complete news archive for NightWatch
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NightWatch
NightWatch was founded in 2013 and raised its 1st funding round 5 years after it was founded.
NightWatch is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
Jeroen Van Den Hout is the current CEO of NightWatch.
NightWatch was founded in 2013 in Leiden, Netherlands, within the health technology sector. Wearable armbands are developed to monitor heart rate and motion during sleep, enabling detection of tonic and tonic-clonic epileptic seizures. Wireless alerts are transmitted to a base station to notify caregivers of potential risks. The focus remains on supporting epilepsy management through this non-invasive device for overnight use.
NightWatch offers NightWatch Device.
NightWatch has 5 investors. Key investors include European Union, Oost NL, EIC Fund, Health Innovations, and Holland Capital.